At the cut-off of PSAD 0, 84 ng / ml2, the AUC to predict clinically significant prostate cancer was 0, 822 with 67, 3% sensitivity, 90, 9% specificity, 91, 7% positive predictive value and 65, 2% negative predictive value for the diagnosis of clinically significant cancer.